Shree Hari Chemicals Export Sets November 6 Results Review

Shree Hari Chemicals Export Limited will review unaudited September 2026 quarter and half-year results on November 6, 2026, after reporting Q1 FY27 revenue of ₹55.63 crore and profit of ₹5.92 crore. The board meeting is the next scheduled earnings event for the BSE-listed company and will cover both standalone and consolidated financial statements.

What will Shree Hari Chemicals Export consider on November 6?

Shree Hari Chemicals Export will consider and approve unaudited financial results for the quarter and half year ended September 30, 2026. The company disclosed the board meeting through an intimation dated October 30, 2026, referring to the approval of standalone and consolidated results.

The meeting is scheduled for Friday, November 6. It follows the company’s previous board meeting on August 14, 2026, when it considered unaudited results for the quarter ended June 2026. The September-quarter announcement will therefore provide the first reported view of performance for the second quarter of FY27 and the first six months of the financial year.

The disclosure was made under the Securities and Exchange Board of India’s Listing Obligations and Disclosure Requirements Regulations, 2015. The results will be relevant because the June quarter showed a return to profitability after uneven quarterly earnings in the preceding financial periods.

How did Shree Hari Chemicals Export perform in Q1 FY27?

Shree Hari Chemicals Export reported Q1 FY27 revenue of ₹55.63 crore and net profit of ₹5.92 crore for the quarter ended June 2026. Another results summary cited revenue from operations of ₹54.9 crore and net profit of ₹5.9 crore, with the differences reflecting the level of rounding used in the reported data.

The company’s June-quarter revenue was reported to have increased 125.9% year on year, while consolidated revenue increased 28.5% quarter on quarter in the available results summary. Net profit rose 469.2% sequentially, according to the same summary, and earnings per share stood at ₹9.41.

Standalone sales for the June 2026 quarter were ₹54.91 crore, compared with ₹41.22 crore in the March 2026 quarter and ₹24.32 crore in the June 2025 quarter. A separate quarterly data set showed operating profit of about ₹8 crore in June 2026, with operating margin of 14.2%, compared with an operating loss of about ₹2 crore in June 2025.

Why is the September-quarter result important for investors?

The September-quarter result is important because it will show whether Shree Hari Chemicals Export sustained the June-quarter improvement in revenue and profitability. The company moved from a reported net loss of about ₹2 crore in the June 2025 quarter to a profit of about ₹6 crore in the June 2026 quarter.

Quarterly results available for the prior year show considerable variation. Revenue was ₹74 crore in September 2025, ₹44 crore in December 2025 and ₹41 crore in March 2026, before rising to ₹55 crore in June 2026. Reported profit after tax over the same sequence was ₹4 crore, ₹1 crore, ₹1 crore and ₹6 crore, respectively.

These movements make the upcoming release more material than a routine compliance update. Investors will be able to compare the September result with the high revenue base recorded in September 2025 and assess the half-year financial position using the company’s disclosed standalone and consolidated statements.

What are the trading-window and compliance details?

Shree Hari Chemicals Export closed its trading window for company securities from October 1, 2026, until 48 hours after the board meeting and result declaration. The company has said that the window will reopen on Monday, November 9, 2026.

Trading-window closures are required to restrict dealing by designated persons while unpublished price-sensitive information is being considered. In this case, the restriction covers the period around the preparation and approval of September-quarter and half-year financial results, as well as other unpublished price-sensitive information cited by the company.

The company also received a confirmation certificate from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, for the quarter ended September 30, 2026. The certificate related to the acceptance or rejection of securities for dematerialisation under Regulation 74(5) of the SEBI Depositories and Participants Regulations, 2018.

What should the market assess after the results are released?

The market should assess Shree Hari Chemicals Export’s reported revenue, expenses, operating profitability, net profit and cash-flow-related disclosures once the September-quarter statements are released. A like-for-like comparison with the September 2025 quarter will be particularly useful because that period recorded revenue of ₹74 crore in the quarterly data provided.

Investors may also monitor whether the company comments on capacity utilisation. The available management summary noted incremental capacity utilisation as a key driver, while also stating that no formal FY27 revenue or margin guidance had been provided. Until the board-approved results are disclosed, no September-quarter financial outcome has been announced.

Conclusion

Shree Hari Chemicals Export’s November 6 board meeting will determine the release of unaudited September-quarter and first-half FY27 results. The update follows a June-quarter performance in which reported revenue reached ₹55.63 crore and net profit reached ₹5.92 crore, marking a significant improvement from the prior-year June quarter.

The next confirmed event is the board’s consideration of the results on November 6, followed by the scheduled reopening of the trading window on November 9. Investors will look for the disclosed September-quarter figures, the half-year comparison and any company comments on capacity utilisation or operating conditions.